LCI
$5.52
Lannett CO
($.06)
(1.08%)
LCI
Earnings Whisper ®
N/A
4th Quarter June 2019
Consensus:  $0.21
Revenue:  $121.43 Mil
Monday
Aug 5
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LCI reports earnings?
Beat
Meet
Miss

Where is LCI's stock price going from here?
Up
Flat
Down
Stock chart of LCI
Analysts
Summary of analysts' recommendations for LCI
Score
Grade
Pivots
Resistance
$5.92
$5.85
$5.71

$5.64

Support
$5.50
$5.43
$5.29
Tweet
Growth
Description
Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, the Company contract manufactures and private labels pharmaceutical products for other companies.
Peers
Regeneron PharmaceuticalsInterCeptMylanBioMarin PharmaceuticalCelgeneVertex PharmaceuticalsZoetisEndo International plcJohnson & JohnsonBristol-Myers Squibb